Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphadenectomy
This randomized phase III trial is studying giving radiation therapy together with
chemotherapy to see how well it works compared to radiation therapy alone in treating
patients with stage I or stage II cervical cancer who previously underwent surgery.
Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy,
such as cisplatin, work in different ways to stop the growth of tumor cells, either by
killing the cells or by stopping them from dividing. It is not yet known whether giving
radiation therapy together with chemotherapy is more effective than radiation therapy alone
in treating patients with cervical cancer.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.